Chacruna Institute for Psychedelic Plant Medicines is a registered California 501(c)(3) non-profit organization (EIN 84-3076078). We are a community-oriented organization run by a small staff of experts and enthusiastic volunteers who work to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal, and health care systems.
Help us to achieve our mission! From our beginnings in 2017, we have stood apart from other psychedelic education and advocacy organizations by pioneering initiatives that support and provide a platform for diverse voices, including women, queer people, people of color, Indigenous people, and the Global South. In efforts to address the lack of diverse representation in the expanding psychedelic landscape, we centered our mission around the empowerment of marginalized voices to foster cultural and political reflections on topics like race, gender, and sexuality in psychedelic science. We believe now more than ever, given the current social and political climate, our work is critical to the future of psychedelic healing for humanity.
Please become a member so that you are able to help Chacruna, yourself, and the world. Support of any amount helps this cause and allows us to provide psychedelic education to anyone who wants to access it.
Sean McAllister responds to Matthew Duffy’s criticism of Colorado’s Natural Medicine Health Act. McAllister cites provisions for grass-roots providers and more egalitarian rules, with low-income people’s access a priority.
These documents show exchanges between members of the Veteran Mental Health Leadership Coalition (VMHLC) and government groups which discuss the support of the Right to Try Clarification Act and the possibility of establishing an inter-agency taskforce on the proper use and deployment of psychedelic medicine and therapy for addressing the current mental health crisis among veterans and the public.
This article by Bia Labate and Kevin Feeney explores problematic actions taken by Decriminalize Nature (DN), in regards to the peyote cactus, in their efforts to build a political movement to decriminalize various psychedelic plants and fungi. DN continues to ignore the voices and requests of Native Americans who are being directly affected by this effort.
In light of recent claims made by Decriminalize Nature (DN), the Cactus Conservation Instititute (CCI) would like to clarify that they as an organization are not aligned with DN or any other political organizations. The links to the articles and claims referred to can be accessed in this note.
As Oregon furthers the process of Psilocybin use under Measure 109, there have been a lot of concerns and criticisms surrounding the framework of this act. This article addresses many of those concerns and specifies proposed precautions the framework will take in order to ensure accessibility and safety.
MEDIA CONTACTSAlray Nelson, Communications Director Kyron Hardy, Public Information Officer Kolton Nephew, Legislative Staff Writer E-mail: [email protected] Phone: (928) 565-0440
FOR IMMEDIATE RELEASE: May 26,...
This is the speech address given by Thomas Eckert for the Horizons conference in New York City in 2021. He speaks on Measure 109, his participation on the Oregon Psilocybin Advisory Board, and his late wife Sheri Eckert who was also an advocate and inspiration in the fight to decriminalize psilocybin mushrooms in Oregon.
This article provides an update on two separate cases in U.S. federal court involving the religious use of ayahuasca—one in Florida brought by Soul Quest and one in Arizona brought by the Arizona Yagé Assembly. Both organizations are suing the DEA to vindicate their religious rights. Chacruna’s Council for the Protection of Sacred Plants reflects on the status of both cases in facing these blatant injustices and how they might impact other organizations using ayahuasca as a sacrament.
This article takes a look at the controversies surrounding patenting psychedelics by analyzing the history of patents as a whole and applying this to the quickly emerging decriminalization and legalization of psychedelics. Chris Byrnes & Graham Pechenik delve into current policies taking place and describe the potential pros and evident cons of patents in psychedelics.